Co-payments for section 100 injectable and infusible chemotherapy medicines in ºÚÁϳԹÏÍø - information for patients

The Pharmaceutical Benefits Scheme (PBS) co-payments for section 100 (s100) injectable and infusible chemotherapy medicines for ºÚÁϳԹÏÍø residents who are patients of ºÚÁϳԹÏÍø public hospitals are paid by ºÚÁϳԹÏÍø Health.

This means that patients treated by ºÚÁϳԹÏÍø public hospitals do not pay the patient co-payment for s100 injectable and infusible chemotherapy medicines.

Last updated: 20 December 2022

Who is eligible?

ºÚÁϳԹÏÍø residents who are patients of ºÚÁϳԹÏÍø public hospitals and are prescribed s100 injectable and infusible chemotherapy medicines under section 100 of the National Health Act 1953 are eligible. This applies to injectable and infusible medicines listed on the PBS website under the s100 Efficient Funding for Chemotherapy (Public Hospital) schedule.

This includes public non-admitted patients, outpatients or day patients, inpatients on discharge from public hospitals and privately referred, non-admitted patients treated in ºÚÁϳԹÏÍø public hospitals.

The co-payment is paid for by ºÚÁϳԹÏÍø Health for prescriptions filled at ºÚÁϳԹÏÍø public hospital pharmacies or through pharmacies used by ºÚÁϳԹÏÍø public hospital oncology services.

Co-payments for s100 injectable and infusible chemotherapy medicines for patients who access care in the private sector in ºÚÁϳԹÏÍø are not eligible for the s100 co-payment program.

Why are co-payments paid by the ºÚÁϳԹÏÍø Government?

The ºÚÁϳԹÏÍø Government made the commitment to pay co-payments for both s100 injectable and infusible chemotherapy medicines and s100 Highly Specialised Drugs in March 2015 to help ease the financial burden for people with cancer and other chronic conditions.

The s100 co-payment program benefits people living with cancer, as well as those with conditions such as HIV, patients with organ and tissue transplants, schizophrenia, hepatitis, Crohn's disease, ulcerative colitis, cystic fibrosis, psoriatic and rheumatoid arthritis, severe allergic asthma and rare diseases, particularly those affecting children, including juvenile idiopathic arthritis.

How do I fill my prescription?

Prescriptions for s100 injectable and infusible chemotherapy medicines can be filled through ºÚÁϳԹÏÍø public hospital pharmacies or pharmacies used by ºÚÁϳԹÏÍø public hospital oncology services.

Why do I have to fill in a consent form?

When your prescription is filled at pharmacies used by ºÚÁϳԹÏÍø public hospital oncology services you sign a local pharmacy consent form. This form also indicates your agreement for ºÚÁϳԹÏÍø Health to pay the co-payment on your behalf and acknowledges that some details will be provided to ºÚÁϳԹÏÍø Health to make the co-payment and evaluate the s100 co-payment program.
Patients who do not complete the consent form and provide it to their pharmacist may be required to pay the co-payment for their medicines.

What are s100 injectable and infusible chemotherapy medicines?

Injectable and infusible chemotherapy is used for the treatment of some cancers. ºÚÁϳԹÏÍø Health does not pay the co-payment for chemotherapy listed on the general schedule of the PBS. Decisions about how medicines are listed on the PBS are made by the Australian Government.

A full list of s100 injectable and infusible chemotherapy medicines is available on PBS.

How do we keep your information private?

ºÚÁϳԹÏÍø Health is committed to safeguarding the privacy of personal information and complying with its privacy obligations. For more information on how ºÚÁϳԹÏÍø Health manages your personal information visit Privacy statement.

More information

Talk to your doctor or oncology service nurse about whether you are eligible for this program.


Current as at: Tuesday 20 December 2022
Contact page owner: Strategic Reform and Planning